What US-India Trade Deal Will Mean For Indian Pharma
U.S.–India trade talks could reshape the $20B pharma export market, as new tariffs and IP disputes put generics, APIs, and vaccine supply chains under pressure.
biosimilars
Strategies For Cos. Navigating US-Indian Pharma Partnerships
U.S.–India pharma partnerships are evolving fast. With shifting regulations and strategic opportunities on both sides, companies must align on compliance, innovation, and collaboration to stay competitive.